STK11 and cancer: Up to now, therapeutic approaches for STK11 mutant cancer were mainly conducted through the restoration of the mTOR pathway using mTOR inhibitors or phenformin, an analog of metformin, without taking into account the potential dual effect of STK11 mutations [25].